The use of NNMT inhibitors as a potential obesity treatment has been investigated preclinically 8,9,13 , and observational clinical data suggests that increased NNMT expression and activity correlate with increased incidence of Type 2 diabetes (T2D) and risk of obesity, respectively 10,11
These may include pain, redness or swelling at the injection site, mild diarrhea, nausea, or itching of the skin
5-amino-1MQ offers yet another mechanism, inhibiting the NNMT enzyme that plays a role in fat cell metabolism
Christophe IMG 7195Membre de SSD et administrateur depuis le 1er janvier 2019, Christophe est mdecin spcialiste en urologie et a effectu toute sa carrire dans le trs rput service d'urologie des Cliniques de l'Europe Bruxelles, service dont il a assum la responsabilit pendant de nombreuses annes
I have received excellent care with the staff